샘플 요청 목록

 카트 문의
시장보고서
상품코드
1798905

세계의 헤마토크릿 검사 기기 시장

Hematocrit Test Devices
발행일: | 리서치사: Global Industry Analysts, Inc. | 페이지 정보: 영문 287 Pages | 배송안내 : 1-2일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

헤마토크릿 검사 기기 세계 시장은 2030년까지 64억 달러에 달할 전망

2024년에 56억 달러로 추정되는 헤마토크릿 검사 기기 세계 시장은 분석 기간인 2024-2030년에 CAGR 2.4%로 성장하여 2030년에는 64억 달러에 달할 것으로 예측됩니다. 이 보고서에서 분석한 부문 중 하나인 혈액 분석기는 CAGR 2.8%를 기록하며 분석 기간 종료시에는 36억 달러에 달할 것으로 예측됩니다. 헤마토크릿 측정기 부문의 성장률은 분석 기간 동안 CAGR 1.8%로 추정됩니다.

미국 시장은 15억 달러, 중국은 CAGR 4.8%로 성장 예측

미국의 헤마토크릿 검사 기기 시장은 2024년에 15억 달러로 추정됩니다. 세계 2위 경제 대국인 중국은 분석 기간인 2024-2030년 CAGR 4.8%로 성장하여 2030년까지 12억 달러의 시장 규모에 달할 것으로 예측됩니다. 기타 주목할 만한 지역별 시장으로는 일본과 캐나다가 있고, 분석 기간 동안 CAGR은 각각 0.9%와 1.8%로 예측됩니다. 유럽에서는 독일이 CAGR 1.3%로 성장할 것으로 예측됩니다.

세계의 헤마토크릿 검사 기기 시장 - 주요 동향과 촉진요인 정리

헤마토크릿 검사가 임상 진단 및 환자 모니터링에 필수적인 이유는 무엇인가?

헤마토크릿 측정기는 환자의 혈액 내 적혈구 비율을 측정하여 빈혈, 탈수, 다혈증, 출혈 등의 상태에 대한 중요한 인사이트를 제공합니다. 이 장비는 병원, 외래 진료소, 응급실, 혈액은행, 재택의료 현장에서 일상적인 혈액 분석 및 치료 모니터링의 일부로 사용되고 있습니다. 헤마토크릿 수치는 산소 운반 능력 평가, 혈액 질환 진단, 체액 균형 평가에 필수적입니다. 이 검사는 투석, 화학요법, 대수술을 받은 환자들에게 특히 중요하며, 적혈구 수치를 정기적으로 모니터링해야 합니다.

검사 장비는 검사실에서 사용하는 탁상형 분석기부터 침대 옆이나 현장에서 사용하기에 적합한 휴대용 Point-of-Care 장비까지 다양한 종류가 있습니다. 검사실 접근성이 제한된 지역에서 휴대용 헤마토크릿 측정기는 복잡한 인프라를 필요로 하지 않고 신속하고 신뢰할 수 있는 결과를 제공합니다. 만성질환의 증가와 분산형 진단 모델의 확대로 인해 일상적인 임상 워크플로우와 장기적인 환자 치료에서 헤마토크릿 검사의 역할이 강화되고 있습니다.

정확성, 속도, 접근성을 향상시키는 기술이란?

최신 헤마토크릿 검사 기기에서는 적혈구량을 측정하기 위해 미량원심분리법, 전도도 측정법, 광학 검출법이 사용되고 있습니다. POC(Point-of-Care) 기기는 모세혈관 혈액 샘플을 사용하는 경우가 많으며, 작업자 교육이 최소화되고, 높은 정확도와 거의 즉각적인 결과를 얻을 수 있습니다. 광학 센서, 일회용 검사 스트립, 컴팩트한 일체형 분석기 개발로 일차 진료 및 자원이 제한된 환경에서 폭넓은 적용이 가능해졌습니다.

이 기기는 현재 자동 교정, 실시간 결과 해석, 전자 의료 기록과의 데이터 공유를 위한 통합 연결을 특징으로 합니다. 배터리로 작동하거나 헤마토크릿과 헤모글로빈 및 기타 혈액 지표를 결합한 멀티 파라미터 검사가 가능한 모델도 있습니다. 시약의 안정성과 소형화된 부품의 발전으로 제조업체들은 장비의 소형화 및 비용 절감을 실현하고 있으며, 이러한 시스템을 이동 진료소 및 재택의료에 적용할 수 있도록 하고 있습니다. 이러한 개선으로 진단 속도가 빨라지고, 집중치료와 원격치료 환경 모두에서 폭넓게 사용할 수 있게 되었습니다.

어디에서 채택이 확대되고 있으며, 어떤 헬스케어 환경에서 사용이 촉진되고 있는가?

헤마토크릿 값 검사는 병원과 전문 클리닉, 특히 신장내과, 종양내과, 혈액내과에서 널리 사용되고 있습니다. 헌혈 센터와 수혈 서비스에서는 헌혈자의 적격성과 제품의 품질을 판단하기 위해 헤마토크릿 측정에 의존하고 있습니다. 응급 현장에서 헤마토크릿 수치는 외상의 심각성과 체액 상태를 평가하는 데 도움이 됩니다. 농촌이나 자원이 부족한 환경에서는 지역 보건 프로그램, 임산부 관리, 만성질환 모니터링에 휴대용 헤마토크릿 값이 사용되고 있습니다.

재택의료는 고령 환자의 증가와 개별화된 케어 관리로의 전환으로 인해 채용이 확대되고 있습니다. 산부인과에서는 산모의 빈혈을 모니터링하기 위해 헤마토크릿 검사를 사용하며, 스포츠 의학 전문의는 운동선수의 적혈구 수를 평가합니다. 지리적으로는 북미, 유럽, 아시아 및 아프리카의 신흥 의료 시스템에서 강력한 성장세를 보이고 있으며, 진단에 대한 접근성 향상이 공중보건의 우선순위로 떠오르고 있습니다. 분산형 진단과 가치 기반 의료를 중시하는 의료기관에서는 임상 효율성을 향상시키는 비용 효율적인 도구로 헤마토크릿 측정기를 채택하고 있습니다.

헤마토크릿 검사 기기 시장의 성장은 몇 가지 요인에 의해 초래됩니다...

헤마토크릿 검사 기기 시장의 성장은 만성질환의 유행, 진단의 분산화, 기술의 소형화 등 여러 요인에 의해 주도되고 있습니다. 빈혈, 신부전, 암 발병률의 증가로 인해 입원 및 외래 환자의 헤마토크릿 검사 빈도가 증가하고 있습니다. 휴대용 분석기, 모세관 샘플링 기술, 실시간 데이터 통합의 발전으로 인해 현장 진료의 사용 편의성과 환자 참여도가 향상되고 있습니다. 또한, 임산부 건강 프로그램, 재택의료 프로토콜, 이동식 진단 장치 등 다양한 분야에서 폭넓게 채택되고 있는 것도 성장을 뒷받침하고 있습니다. 의료 시스템이 조기 진단과 원격 모니터링을 우선시하는 가운데, 헤마토크릿 측정기는 정확하고 신속하며 사용하기 쉬운 혈액 분석에 필수적인 도구가 되고 있습니다.

부문

제품(혈액 분석기, 헤마토크릿 검사기, 기타 제품), 최종사용자(병원/외래 수술 센터, 클리닉, 진단·병리 실험실, 기타 최종사용자)

조사 대상 기업 사례

  • Abbott Laboratories
  • ACON Laboratories, Inc.
  • Beckman Coulter, Inc.(Danaher)
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories, Inc.
  • Boule Diagnostics AB
  • Clindiag Systems
  • EKF Diagnostics Holdings plc
  • F. Hoffmann-La Roche Ltd.
  • Greiner Bio-One GmbH
  • HemoCue AB(a Danaher company)
  • Horiba Medical
  • IDEXX Laboratories, Inc.
  • Medonic AB
  • Mindray Bio-Medical Electronics
  • Nihon Kohden Corporation
  • OrSense, Ltd.
  • Siemens Healthineers AG
  • Sysmex Corporation
  • Thermo Fisher Scientific Inc.

AI 통합

Global Industry Analysts는 검증된 전문가 컨텐츠와 AI 툴을 통해 시장 정보와 경쟁 정보를 혁신하고 있습니다.

Global Industry Analysts는 일반적인 LLM 및 업계별 SLM 쿼리를 따르는 대신 비디오 기록, 블로그, 검색 엔진 조사, 방대한 양의 기업, 제품/서비스, 시장 데이터 등 세계 전문가로부터 수집한 컨텐츠 리포지토리를 구축했습니다.

관세 영향 계수

Global Industry Analysts는 본사 소재지, 제조거점, 수출입(완제품 및 OEM)을 기준으로 기업의 경쟁력 변화를 예측하고 있습니다. 이러한 복잡하고 다면적인 시장 역학은 매출원가(COGS) 증가, 수익성 하락, 공급망 재편 등 미시적, 거시적 시장 역학 중에서도 특히 경쟁사들에게 영향을 미칠 것으로 예상됩니다.

목차

제1장 조사 방법

제2장 주요 요약

  • 시장 개요
  • 주요 기업
  • 시장 동향과 촉진요인
  • 세계 시장 전망

제3장 시장 분석

  • 미국
  • 캐나다
  • 일본
  • 중국
  • 유럽
  • 프랑스
  • 독일
  • 이탈리아
  • 영국
  • 스페인
  • 러시아
  • 기타 유럽
  • 아시아태평양
  • 호주
  • 인도
  • 한국
  • 기타 아시아태평양
  • 라틴아메리카
  • 아르헨티나
  • 브라질
  • 멕시코
  • 기타 라틴아메리카
  • 중동
  • 이란
  • 이스라엘
  • 사우디아라비아
  • 아랍에미리트
  • 기타 중동
  • 아프리카

제4장 경쟁

KSM 25.09.03

Global Hematocrit Test Devices Market to Reach US$6.4 Billion by 2030

The global market for Hematocrit Test Devices estimated at US$5.6 Billion in the year 2024, is expected to reach US$6.4 Billion by 2030, growing at a CAGR of 2.4% over the analysis period 2024-2030. Blood Analyzers, one of the segments analyzed in the report, is expected to record a 2.8% CAGR and reach US$3.6 Billion by the end of the analysis period. Growth in the Hematocrit Test Meters segment is estimated at 1.8% CAGR over the analysis period.

The U.S. Market is Estimated at US$1.5 Billion While China is Forecast to Grow at 4.8% CAGR

The Hematocrit Test Devices market in the U.S. is estimated at US$1.5 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$1.2 Billion by the year 2030 trailing a CAGR of 4.8% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 0.9% and 1.8% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 1.3% CAGR.

Global Hematocrit Test Devices Market - Key Trends & Drivers Summarized

Why Are Hematocrit Tests Critical to Clinical Diagnostics and Patient Monitoring?

Hematocrit test devices measure the proportion of red blood cells in a patient’s blood, offering critical insights into conditions such as anemia, dehydration, polycythemia, and blood loss. These devices are used in hospitals, outpatient clinics, emergency departments, blood banks, and home care settings as part of routine blood analysis and treatment monitoring. Hematocrit levels are essential for assessing oxygen-carrying capacity, diagnosing hematologic disorders, and evaluating fluid balance. The test is particularly relevant for patients undergoing dialysis, chemotherapy, or major surgery, where red cell volume needs regular monitoring.

Devices range from benchtop analyzers used in laboratories to portable, point-of-care devices suited for bedside or field use. In regions with limited laboratory access, portable hematocrit analyzers provide rapid, reliable results without the need for complex infrastructure. Increasing incidence of chronic diseases and the expansion of decentralized diagnostic models are reinforcing the role of hematocrit testing in everyday clinical workflows and long-term patient care.

How Are Technologies Advancing Accuracy, Speed, and Accessibility?

Modern hematocrit test devices use microcentrifugation, conductivity measurement, and optical detection methods to determine red blood cell volume. Point-of-care devices often use capillary blood samples and require minimal operator training, providing near-instantaneous results with high accuracy. Developments in optical sensors, disposable test strips, and compact integrated analyzers are enabling broader deployment in primary care and resource-limited environments.

Devices now feature automatic calibration, real-time result interpretation, and integrated connectivity for data sharing with electronic health records. Some models include battery-powered operation and multi-parameter testing, combining hematocrit with hemoglobin and other blood indices. Advances in reagent stability and miniaturized components are helping manufacturers reduce unit size and cost, making these systems viable for mobile clinics and home health applications. These improvements are enhancing diagnostic speed while supporting wider use in both centralized and remote care settings.

Where Is Adoption Growing and Which Healthcare Settings Are Driving Usage?

Hematocrit testing is widely used in hospitals and specialty clinics, particularly nephrology, oncology, and hematology departments. Blood donation centers and transfusion services rely on hematocrit measurement to determine donor eligibility and product quality. In emergency settings, hematocrit levels help assess trauma severity and fluid status. In rural and low-resource settings, portable hematocrit devices are increasingly used in community health programs, maternal care, and chronic disease monitoring.

Adoption is growing in home healthcare due to the rising number of elderly patients and the shift toward personalized care management. Prenatal care centers use hematocrit tests to monitor maternal anemia, while sports medicine practitioners evaluate red cell mass in athletes. Geographic growth is strong in North America, Europe, and emerging healthcare systems in Asia and Africa, where increased access to diagnostics is a public health priority. Institutions focusing on decentralized diagnostics and value-based care are adopting hematocrit test devices as cost-effective tools to improve clinical efficiency.

The Growth in the Hematocrit Test Devices Market Is Driven by Several Factors…

The growth in the hematocrit test devices market is driven by several factors related to chronic disease prevalence, decentralized diagnostics, and technology miniaturization. Rising incidence of anemia, renal failure, and cancer is increasing the frequency of hematocrit testing across inpatient and outpatient settings. Advancements in portable analyzers, capillary sampling techniques, and real-time data integration are improving point-of-care usability and patient engagement. Growth is also supported by broader adoption in maternal health programs, home care protocols, and mobile diagnostic units. As healthcare systems prioritize early diagnosis and remote monitoring, hematocrit test devices are becoming essential tools for accurate, rapid, and accessible blood analysis.

SCOPE OF STUDY:

The report analyzes the Hematocrit Test Devices market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Product (Blood Analyzers, Hematocrit Test Meters, Other Products); End-User (Hospitals / Ambulatory Surgery Centers End-User, Clinics End-User, Diagnostic & Pathology Labs End-User, Other End-Users)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 47 Featured) -

  • Abbott Laboratories
  • ACON Laboratories, Inc.
  • Beckman Coulter, Inc. (Danaher)
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories, Inc.
  • Boule Diagnostics AB
  • Clindiag Systems
  • EKF Diagnostics Holdings plc
  • F. Hoffmann-La Roche Ltd.
  • Greiner Bio-One GmbH
  • HemoCue AB (a Danaher company)
  • Horiba Medical
  • IDEXX Laboratories, Inc.
  • Medonic AB
  • Mindray Bio-Medical Electronics
  • Nihon Kohden Corporation
  • OrSense, Ltd.
  • Siemens Healthineers AG
  • Sysmex Corporation
  • Thermo Fisher Scientific Inc.

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Tariff Impact on Global Supply Chain Patterns
    • Hematocrit Test Devices - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Incidence of Anemia, Dehydration, and Blood Disorders Drives Demand for Hematocrit Testing in Clinical and Home Settings
    • Expansion of Point-of-Care Testing (POCT) Solutions Strengthens Market for Portable and Handheld Hematocrit Analyzers
    • Increased Adoption of Hematocrit Measurement in Pre-Surgical, Dialysis, and ICU Monitoring Enhances Clinical Integration
    • OEM Innovation in Micro-Sample and Capillary-Based Devices Improves Comfort and Accuracy in Pediatric and Geriatric Use
    • Growth in Blood Donation and Transfusion Services Spurs Routine Hematocrit Screening for Donor Eligibility and Safety
    • Technological Advancements in Optical and Centrifugal Measurement Techniques Expand Product Differentiation
    • Integration of Hematocrit Testing Into Multi-Parameter Hematology Devices Streamlines Workflow in Diagnostic Labs
    • Rising Demand for At-Home Monitoring by Chronic Kidney Disease (CKD) and Chemotherapy Patients Supports Telehealth Integration
    • Digital Connectivity Features in New Devices Enable Seamless Data Transfer to EHR and Patient Portals
    • Growing Need for Rapid, On-Site Results in Emergency and Mobile Clinics Fuels Demand for Lightweight, Battery-Operated Devices
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Hematocrit Test Devices Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Hematocrit Test Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Hematocrit Test Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 4: World 16-Year Perspective for Hematocrit Test Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Blood Analyzers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Blood Analyzers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 7: World 16-Year Perspective for Blood Analyzers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Hematocrit Test Meters by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Hematocrit Test Meters by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 10: World 16-Year Perspective for Hematocrit Test Meters by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Other Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Other Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 13: World 16-Year Perspective for Other Products by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Hospitals / Ambulatory Surgery Centers End-User by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Hospitals / Ambulatory Surgery Centers End-User by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 16: World 16-Year Perspective for Hospitals / Ambulatory Surgery Centers End-User by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Clinics End-User by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Clinics End-User by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 19: World 16-Year Perspective for Clinics End-User by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Diagnostic & Pathology Labs End-User by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Diagnostic & Pathology Labs End-User by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 22: World 16-Year Perspective for Diagnostic & Pathology Labs End-User by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Other End-Users by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Other End-Users by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 25: World 16-Year Perspective for Other End-Users by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Hematocrit Test Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 26: USA Recent Past, Current & Future Analysis for Hematocrit Test Devices by Product - Blood Analyzers, Hematocrit Test Meters and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 27: USA Historic Review for Hematocrit Test Devices by Product - Blood Analyzers, Hematocrit Test Meters and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 28: USA 16-Year Perspective for Hematocrit Test Devices by Product - Percentage Breakdown of Value Sales for Blood Analyzers, Hematocrit Test Meters and Other Products for the Years 2014, 2025 & 2030
    • TABLE 29: USA Recent Past, Current & Future Analysis for Hematocrit Test Devices by End-user - Hospitals / Ambulatory Surgery Centers End-User, Clinics End-User, Diagnostic & Pathology Labs End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 30: USA Historic Review for Hematocrit Test Devices by End-user - Hospitals / Ambulatory Surgery Centers End-User, Clinics End-User, Diagnostic & Pathology Labs End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 31: USA 16-Year Perspective for Hematocrit Test Devices by End-user - Percentage Breakdown of Value Sales for Hospitals / Ambulatory Surgery Centers End-User, Clinics End-User, Diagnostic & Pathology Labs End-User and Other End-Users for the Years 2014, 2025 & 2030
  • CANADA
    • TABLE 32: Canada Recent Past, Current & Future Analysis for Hematocrit Test Devices by Product - Blood Analyzers, Hematocrit Test Meters and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 33: Canada Historic Review for Hematocrit Test Devices by Product - Blood Analyzers, Hematocrit Test Meters and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 34: Canada 16-Year Perspective for Hematocrit Test Devices by Product - Percentage Breakdown of Value Sales for Blood Analyzers, Hematocrit Test Meters and Other Products for the Years 2014, 2025 & 2030
    • TABLE 35: Canada Recent Past, Current & Future Analysis for Hematocrit Test Devices by End-user - Hospitals / Ambulatory Surgery Centers End-User, Clinics End-User, Diagnostic & Pathology Labs End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 36: Canada Historic Review for Hematocrit Test Devices by End-user - Hospitals / Ambulatory Surgery Centers End-User, Clinics End-User, Diagnostic & Pathology Labs End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 37: Canada 16-Year Perspective for Hematocrit Test Devices by End-user - Percentage Breakdown of Value Sales for Hospitals / Ambulatory Surgery Centers End-User, Clinics End-User, Diagnostic & Pathology Labs End-User and Other End-Users for the Years 2014, 2025 & 2030
  • JAPAN
    • Hematocrit Test Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 38: Japan Recent Past, Current & Future Analysis for Hematocrit Test Devices by Product - Blood Analyzers, Hematocrit Test Meters and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 39: Japan Historic Review for Hematocrit Test Devices by Product - Blood Analyzers, Hematocrit Test Meters and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 40: Japan 16-Year Perspective for Hematocrit Test Devices by Product - Percentage Breakdown of Value Sales for Blood Analyzers, Hematocrit Test Meters and Other Products for the Years 2014, 2025 & 2030
    • TABLE 41: Japan Recent Past, Current & Future Analysis for Hematocrit Test Devices by End-user - Hospitals / Ambulatory Surgery Centers End-User, Clinics End-User, Diagnostic & Pathology Labs End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 42: Japan Historic Review for Hematocrit Test Devices by End-user - Hospitals / Ambulatory Surgery Centers End-User, Clinics End-User, Diagnostic & Pathology Labs End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 43: Japan 16-Year Perspective for Hematocrit Test Devices by End-user - Percentage Breakdown of Value Sales for Hospitals / Ambulatory Surgery Centers End-User, Clinics End-User, Diagnostic & Pathology Labs End-User and Other End-Users for the Years 2014, 2025 & 2030
  • CHINA
    • Hematocrit Test Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 44: China Recent Past, Current & Future Analysis for Hematocrit Test Devices by Product - Blood Analyzers, Hematocrit Test Meters and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 45: China Historic Review for Hematocrit Test Devices by Product - Blood Analyzers, Hematocrit Test Meters and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 46: China 16-Year Perspective for Hematocrit Test Devices by Product - Percentage Breakdown of Value Sales for Blood Analyzers, Hematocrit Test Meters and Other Products for the Years 2014, 2025 & 2030
    • TABLE 47: China Recent Past, Current & Future Analysis for Hematocrit Test Devices by End-user - Hospitals / Ambulatory Surgery Centers End-User, Clinics End-User, Diagnostic & Pathology Labs End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 48: China Historic Review for Hematocrit Test Devices by End-user - Hospitals / Ambulatory Surgery Centers End-User, Clinics End-User, Diagnostic & Pathology Labs End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 49: China 16-Year Perspective for Hematocrit Test Devices by End-user - Percentage Breakdown of Value Sales for Hospitals / Ambulatory Surgery Centers End-User, Clinics End-User, Diagnostic & Pathology Labs End-User and Other End-Users for the Years 2014, 2025 & 2030
  • EUROPE
    • Hematocrit Test Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 50: Europe Recent Past, Current & Future Analysis for Hematocrit Test Devices by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 51: Europe Historic Review for Hematocrit Test Devices by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 52: Europe 16-Year Perspective for Hematocrit Test Devices by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2025 & 2030
    • TABLE 53: Europe Recent Past, Current & Future Analysis for Hematocrit Test Devices by Product - Blood Analyzers, Hematocrit Test Meters and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 54: Europe Historic Review for Hematocrit Test Devices by Product - Blood Analyzers, Hematocrit Test Meters and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 55: Europe 16-Year Perspective for Hematocrit Test Devices by Product - Percentage Breakdown of Value Sales for Blood Analyzers, Hematocrit Test Meters and Other Products for the Years 2014, 2025 & 2030
    • TABLE 56: Europe Recent Past, Current & Future Analysis for Hematocrit Test Devices by End-user - Hospitals / Ambulatory Surgery Centers End-User, Clinics End-User, Diagnostic & Pathology Labs End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Europe Historic Review for Hematocrit Test Devices by End-user - Hospitals / Ambulatory Surgery Centers End-User, Clinics End-User, Diagnostic & Pathology Labs End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 58: Europe 16-Year Perspective for Hematocrit Test Devices by End-user - Percentage Breakdown of Value Sales for Hospitals / Ambulatory Surgery Centers End-User, Clinics End-User, Diagnostic & Pathology Labs End-User and Other End-Users for the Years 2014, 2025 & 2030
  • FRANCE
    • Hematocrit Test Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 59: France Recent Past, Current & Future Analysis for Hematocrit Test Devices by Product - Blood Analyzers, Hematocrit Test Meters and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 60: France Historic Review for Hematocrit Test Devices by Product - Blood Analyzers, Hematocrit Test Meters and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 61: France 16-Year Perspective for Hematocrit Test Devices by Product - Percentage Breakdown of Value Sales for Blood Analyzers, Hematocrit Test Meters and Other Products for the Years 2014, 2025 & 2030
    • TABLE 62: France Recent Past, Current & Future Analysis for Hematocrit Test Devices by End-user - Hospitals / Ambulatory Surgery Centers End-User, Clinics End-User, Diagnostic & Pathology Labs End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 63: France Historic Review for Hematocrit Test Devices by End-user - Hospitals / Ambulatory Surgery Centers End-User, Clinics End-User, Diagnostic & Pathology Labs End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 64: France 16-Year Perspective for Hematocrit Test Devices by End-user - Percentage Breakdown of Value Sales for Hospitals / Ambulatory Surgery Centers End-User, Clinics End-User, Diagnostic & Pathology Labs End-User and Other End-Users for the Years 2014, 2025 & 2030
  • GERMANY
    • Hematocrit Test Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 65: Germany Recent Past, Current & Future Analysis for Hematocrit Test Devices by Product - Blood Analyzers, Hematocrit Test Meters and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 66: Germany Historic Review for Hematocrit Test Devices by Product - Blood Analyzers, Hematocrit Test Meters and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 67: Germany 16-Year Perspective for Hematocrit Test Devices by Product - Percentage Breakdown of Value Sales for Blood Analyzers, Hematocrit Test Meters and Other Products for the Years 2014, 2025 & 2030
    • TABLE 68: Germany Recent Past, Current & Future Analysis for Hematocrit Test Devices by End-user - Hospitals / Ambulatory Surgery Centers End-User, Clinics End-User, Diagnostic & Pathology Labs End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Germany Historic Review for Hematocrit Test Devices by End-user - Hospitals / Ambulatory Surgery Centers End-User, Clinics End-User, Diagnostic & Pathology Labs End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 70: Germany 16-Year Perspective for Hematocrit Test Devices by End-user - Percentage Breakdown of Value Sales for Hospitals / Ambulatory Surgery Centers End-User, Clinics End-User, Diagnostic & Pathology Labs End-User and Other End-Users for the Years 2014, 2025 & 2030
  • ITALY
    • TABLE 71: Italy Recent Past, Current & Future Analysis for Hematocrit Test Devices by Product - Blood Analyzers, Hematocrit Test Meters and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 72: Italy Historic Review for Hematocrit Test Devices by Product - Blood Analyzers, Hematocrit Test Meters and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 73: Italy 16-Year Perspective for Hematocrit Test Devices by Product - Percentage Breakdown of Value Sales for Blood Analyzers, Hematocrit Test Meters and Other Products for the Years 2014, 2025 & 2030
    • TABLE 74: Italy Recent Past, Current & Future Analysis for Hematocrit Test Devices by End-user - Hospitals / Ambulatory Surgery Centers End-User, Clinics End-User, Diagnostic & Pathology Labs End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Italy Historic Review for Hematocrit Test Devices by End-user - Hospitals / Ambulatory Surgery Centers End-User, Clinics End-User, Diagnostic & Pathology Labs End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 76: Italy 16-Year Perspective for Hematocrit Test Devices by End-user - Percentage Breakdown of Value Sales for Hospitals / Ambulatory Surgery Centers End-User, Clinics End-User, Diagnostic & Pathology Labs End-User and Other End-Users for the Years 2014, 2025 & 2030
  • UNITED KINGDOM
    • Hematocrit Test Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 77: UK Recent Past, Current & Future Analysis for Hematocrit Test Devices by Product - Blood Analyzers, Hematocrit Test Meters and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 78: UK Historic Review for Hematocrit Test Devices by Product - Blood Analyzers, Hematocrit Test Meters and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 79: UK 16-Year Perspective for Hematocrit Test Devices by Product - Percentage Breakdown of Value Sales for Blood Analyzers, Hematocrit Test Meters and Other Products for the Years 2014, 2025 & 2030
    • TABLE 80: UK Recent Past, Current & Future Analysis for Hematocrit Test Devices by End-user - Hospitals / Ambulatory Surgery Centers End-User, Clinics End-User, Diagnostic & Pathology Labs End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 81: UK Historic Review for Hematocrit Test Devices by End-user - Hospitals / Ambulatory Surgery Centers End-User, Clinics End-User, Diagnostic & Pathology Labs End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 82: UK 16-Year Perspective for Hematocrit Test Devices by End-user - Percentage Breakdown of Value Sales for Hospitals / Ambulatory Surgery Centers End-User, Clinics End-User, Diagnostic & Pathology Labs End-User and Other End-Users for the Years 2014, 2025 & 2030
  • SPAIN
    • TABLE 83: Spain Recent Past, Current & Future Analysis for Hematocrit Test Devices by Product - Blood Analyzers, Hematocrit Test Meters and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Spain Historic Review for Hematocrit Test Devices by Product - Blood Analyzers, Hematocrit Test Meters and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 85: Spain 16-Year Perspective for Hematocrit Test Devices by Product - Percentage Breakdown of Value Sales for Blood Analyzers, Hematocrit Test Meters and Other Products for the Years 2014, 2025 & 2030
    • TABLE 86: Spain Recent Past, Current & Future Analysis for Hematocrit Test Devices by End-user - Hospitals / Ambulatory Surgery Centers End-User, Clinics End-User, Diagnostic & Pathology Labs End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Spain Historic Review for Hematocrit Test Devices by End-user - Hospitals / Ambulatory Surgery Centers End-User, Clinics End-User, Diagnostic & Pathology Labs End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 88: Spain 16-Year Perspective for Hematocrit Test Devices by End-user - Percentage Breakdown of Value Sales for Hospitals / Ambulatory Surgery Centers End-User, Clinics End-User, Diagnostic & Pathology Labs End-User and Other End-Users for the Years 2014, 2025 & 2030
  • RUSSIA
    • TABLE 89: Russia Recent Past, Current & Future Analysis for Hematocrit Test Devices by Product - Blood Analyzers, Hematocrit Test Meters and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Russia Historic Review for Hematocrit Test Devices by Product - Blood Analyzers, Hematocrit Test Meters and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 91: Russia 16-Year Perspective for Hematocrit Test Devices by Product - Percentage Breakdown of Value Sales for Blood Analyzers, Hematocrit Test Meters and Other Products for the Years 2014, 2025 & 2030
    • TABLE 92: Russia Recent Past, Current & Future Analysis for Hematocrit Test Devices by End-user - Hospitals / Ambulatory Surgery Centers End-User, Clinics End-User, Diagnostic & Pathology Labs End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Russia Historic Review for Hematocrit Test Devices by End-user - Hospitals / Ambulatory Surgery Centers End-User, Clinics End-User, Diagnostic & Pathology Labs End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 94: Russia 16-Year Perspective for Hematocrit Test Devices by End-user - Percentage Breakdown of Value Sales for Hospitals / Ambulatory Surgery Centers End-User, Clinics End-User, Diagnostic & Pathology Labs End-User and Other End-Users for the Years 2014, 2025 & 2030
  • REST OF EUROPE
    • TABLE 95: Rest of Europe Recent Past, Current & Future Analysis for Hematocrit Test Devices by Product - Blood Analyzers, Hematocrit Test Meters and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Rest of Europe Historic Review for Hematocrit Test Devices by Product - Blood Analyzers, Hematocrit Test Meters and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 97: Rest of Europe 16-Year Perspective for Hematocrit Test Devices by Product - Percentage Breakdown of Value Sales for Blood Analyzers, Hematocrit Test Meters and Other Products for the Years 2014, 2025 & 2030
    • TABLE 98: Rest of Europe Recent Past, Current & Future Analysis for Hematocrit Test Devices by End-user - Hospitals / Ambulatory Surgery Centers End-User, Clinics End-User, Diagnostic & Pathology Labs End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Rest of Europe Historic Review for Hematocrit Test Devices by End-user - Hospitals / Ambulatory Surgery Centers End-User, Clinics End-User, Diagnostic & Pathology Labs End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 100: Rest of Europe 16-Year Perspective for Hematocrit Test Devices by End-user - Percentage Breakdown of Value Sales for Hospitals / Ambulatory Surgery Centers End-User, Clinics End-User, Diagnostic & Pathology Labs End-User and Other End-Users for the Years 2014, 2025 & 2030
  • ASIA-PACIFIC
    • Hematocrit Test Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 101: Asia-Pacific Recent Past, Current & Future Analysis for Hematocrit Test Devices by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 102: Asia-Pacific Historic Review for Hematocrit Test Devices by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 103: Asia-Pacific 16-Year Perspective for Hematocrit Test Devices by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2025 & 2030
    • TABLE 104: Asia-Pacific Recent Past, Current & Future Analysis for Hematocrit Test Devices by Product - Blood Analyzers, Hematocrit Test Meters and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Asia-Pacific Historic Review for Hematocrit Test Devices by Product - Blood Analyzers, Hematocrit Test Meters and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 106: Asia-Pacific 16-Year Perspective for Hematocrit Test Devices by Product - Percentage Breakdown of Value Sales for Blood Analyzers, Hematocrit Test Meters and Other Products for the Years 2014, 2025 & 2030
    • TABLE 107: Asia-Pacific Recent Past, Current & Future Analysis for Hematocrit Test Devices by End-user - Hospitals / Ambulatory Surgery Centers End-User, Clinics End-User, Diagnostic & Pathology Labs End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Asia-Pacific Historic Review for Hematocrit Test Devices by End-user - Hospitals / Ambulatory Surgery Centers End-User, Clinics End-User, Diagnostic & Pathology Labs End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 109: Asia-Pacific 16-Year Perspective for Hematocrit Test Devices by End-user - Percentage Breakdown of Value Sales for Hospitals / Ambulatory Surgery Centers End-User, Clinics End-User, Diagnostic & Pathology Labs End-User and Other End-Users for the Years 2014, 2025 & 2030
  • AUSTRALIA
    • Hematocrit Test Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 110: Australia Recent Past, Current & Future Analysis for Hematocrit Test Devices by Product - Blood Analyzers, Hematocrit Test Meters and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Australia Historic Review for Hematocrit Test Devices by Product - Blood Analyzers, Hematocrit Test Meters and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 112: Australia 16-Year Perspective for Hematocrit Test Devices by Product - Percentage Breakdown of Value Sales for Blood Analyzers, Hematocrit Test Meters and Other Products for the Years 2014, 2025 & 2030
    • TABLE 113: Australia Recent Past, Current & Future Analysis for Hematocrit Test Devices by End-user - Hospitals / Ambulatory Surgery Centers End-User, Clinics End-User, Diagnostic & Pathology Labs End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 114: Australia Historic Review for Hematocrit Test Devices by End-user - Hospitals / Ambulatory Surgery Centers End-User, Clinics End-User, Diagnostic & Pathology Labs End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 115: Australia 16-Year Perspective for Hematocrit Test Devices by End-user - Percentage Breakdown of Value Sales for Hospitals / Ambulatory Surgery Centers End-User, Clinics End-User, Diagnostic & Pathology Labs End-User and Other End-Users for the Years 2014, 2025 & 2030
  • INDIA
    • Hematocrit Test Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 116: India Recent Past, Current & Future Analysis for Hematocrit Test Devices by Product - Blood Analyzers, Hematocrit Test Meters and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 117: India Historic Review for Hematocrit Test Devices by Product - Blood Analyzers, Hematocrit Test Meters and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 118: India 16-Year Perspective for Hematocrit Test Devices by Product - Percentage Breakdown of Value Sales for Blood Analyzers, Hematocrit Test Meters and Other Products for the Years 2014, 2025 & 2030
    • TABLE 119: India Recent Past, Current & Future Analysis for Hematocrit Test Devices by End-user - Hospitals / Ambulatory Surgery Centers End-User, Clinics End-User, Diagnostic & Pathology Labs End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 120: India Historic Review for Hematocrit Test Devices by End-user - Hospitals / Ambulatory Surgery Centers End-User, Clinics End-User, Diagnostic & Pathology Labs End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 121: India 16-Year Perspective for Hematocrit Test Devices by End-user - Percentage Breakdown of Value Sales for Hospitals / Ambulatory Surgery Centers End-User, Clinics End-User, Diagnostic & Pathology Labs End-User and Other End-Users for the Years 2014, 2025 & 2030
  • SOUTH KOREA
    • TABLE 122: South Korea Recent Past, Current & Future Analysis for Hematocrit Test Devices by Product - Blood Analyzers, Hematocrit Test Meters and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 123: South Korea Historic Review for Hematocrit Test Devices by Product - Blood Analyzers, Hematocrit Test Meters and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 124: South Korea 16-Year Perspective for Hematocrit Test Devices by Product - Percentage Breakdown of Value Sales for Blood Analyzers, Hematocrit Test Meters and Other Products for the Years 2014, 2025 & 2030
    • TABLE 125: South Korea Recent Past, Current & Future Analysis for Hematocrit Test Devices by End-user - Hospitals / Ambulatory Surgery Centers End-User, Clinics End-User, Diagnostic & Pathology Labs End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 126: South Korea Historic Review for Hematocrit Test Devices by End-user - Hospitals / Ambulatory Surgery Centers End-User, Clinics End-User, Diagnostic & Pathology Labs End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 127: South Korea 16-Year Perspective for Hematocrit Test Devices by End-user - Percentage Breakdown of Value Sales for Hospitals / Ambulatory Surgery Centers End-User, Clinics End-User, Diagnostic & Pathology Labs End-User and Other End-Users for the Years 2014, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 128: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Hematocrit Test Devices by Product - Blood Analyzers, Hematocrit Test Meters and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Rest of Asia-Pacific Historic Review for Hematocrit Test Devices by Product - Blood Analyzers, Hematocrit Test Meters and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 130: Rest of Asia-Pacific 16-Year Perspective for Hematocrit Test Devices by Product - Percentage Breakdown of Value Sales for Blood Analyzers, Hematocrit Test Meters and Other Products for the Years 2014, 2025 & 2030
    • TABLE 131: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Hematocrit Test Devices by End-user - Hospitals / Ambulatory Surgery Centers End-User, Clinics End-User, Diagnostic & Pathology Labs End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 132: Rest of Asia-Pacific Historic Review for Hematocrit Test Devices by End-user - Hospitals / Ambulatory Surgery Centers End-User, Clinics End-User, Diagnostic & Pathology Labs End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 133: Rest of Asia-Pacific 16-Year Perspective for Hematocrit Test Devices by End-user - Percentage Breakdown of Value Sales for Hospitals / Ambulatory Surgery Centers End-User, Clinics End-User, Diagnostic & Pathology Labs End-User and Other End-Users for the Years 2014, 2025 & 2030
  • LATIN AMERICA
    • Hematocrit Test Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 134: Latin America Recent Past, Current & Future Analysis for Hematocrit Test Devices by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 135: Latin America Historic Review for Hematocrit Test Devices by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 136: Latin America 16-Year Perspective for Hematocrit Test Devices by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2025 & 2030
    • TABLE 137: Latin America Recent Past, Current & Future Analysis for Hematocrit Test Devices by Product - Blood Analyzers, Hematocrit Test Meters and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Latin America Historic Review for Hematocrit Test Devices by Product - Blood Analyzers, Hematocrit Test Meters and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 139: Latin America 16-Year Perspective for Hematocrit Test Devices by Product - Percentage Breakdown of Value Sales for Blood Analyzers, Hematocrit Test Meters and Other Products for the Years 2014, 2025 & 2030
    • TABLE 140: Latin America Recent Past, Current & Future Analysis for Hematocrit Test Devices by End-user - Hospitals / Ambulatory Surgery Centers End-User, Clinics End-User, Diagnostic & Pathology Labs End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Latin America Historic Review for Hematocrit Test Devices by End-user - Hospitals / Ambulatory Surgery Centers End-User, Clinics End-User, Diagnostic & Pathology Labs End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 142: Latin America 16-Year Perspective for Hematocrit Test Devices by End-user - Percentage Breakdown of Value Sales for Hospitals / Ambulatory Surgery Centers End-User, Clinics End-User, Diagnostic & Pathology Labs End-User and Other End-Users for the Years 2014, 2025 & 2030
  • ARGENTINA
    • TABLE 143: Argentina Recent Past, Current & Future Analysis for Hematocrit Test Devices by Product - Blood Analyzers, Hematocrit Test Meters and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Argentina Historic Review for Hematocrit Test Devices by Product - Blood Analyzers, Hematocrit Test Meters and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 145: Argentina 16-Year Perspective for Hematocrit Test Devices by Product - Percentage Breakdown of Value Sales for Blood Analyzers, Hematocrit Test Meters and Other Products for the Years 2014, 2025 & 2030
    • TABLE 146: Argentina Recent Past, Current & Future Analysis for Hematocrit Test Devices by End-user - Hospitals / Ambulatory Surgery Centers End-User, Clinics End-User, Diagnostic & Pathology Labs End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Argentina Historic Review for Hematocrit Test Devices by End-user - Hospitals / Ambulatory Surgery Centers End-User, Clinics End-User, Diagnostic & Pathology Labs End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 148: Argentina 16-Year Perspective for Hematocrit Test Devices by End-user - Percentage Breakdown of Value Sales for Hospitals / Ambulatory Surgery Centers End-User, Clinics End-User, Diagnostic & Pathology Labs End-User and Other End-Users for the Years 2014, 2025 & 2030
  • BRAZIL
    • TABLE 149: Brazil Recent Past, Current & Future Analysis for Hematocrit Test Devices by Product - Blood Analyzers, Hematocrit Test Meters and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Brazil Historic Review for Hematocrit Test Devices by Product - Blood Analyzers, Hematocrit Test Meters and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 151: Brazil 16-Year Perspective for Hematocrit Test Devices by Product - Percentage Breakdown of Value Sales for Blood Analyzers, Hematocrit Test Meters and Other Products for the Years 2014, 2025 & 2030
    • TABLE 152: Brazil Recent Past, Current & Future Analysis for Hematocrit Test Devices by End-user - Hospitals / Ambulatory Surgery Centers End-User, Clinics End-User, Diagnostic & Pathology Labs End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Brazil Historic Review for Hematocrit Test Devices by End-user - Hospitals / Ambulatory Surgery Centers End-User, Clinics End-User, Diagnostic & Pathology Labs End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 154: Brazil 16-Year Perspective for Hematocrit Test Devices by End-user - Percentage Breakdown of Value Sales for Hospitals / Ambulatory Surgery Centers End-User, Clinics End-User, Diagnostic & Pathology Labs End-User and Other End-Users for the Years 2014, 2025 & 2030
  • MEXICO
    • TABLE 155: Mexico Recent Past, Current & Future Analysis for Hematocrit Test Devices by Product - Blood Analyzers, Hematocrit Test Meters and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Mexico Historic Review for Hematocrit Test Devices by Product - Blood Analyzers, Hematocrit Test Meters and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 157: Mexico 16-Year Perspective for Hematocrit Test Devices by Product - Percentage Breakdown of Value Sales for Blood Analyzers, Hematocrit Test Meters and Other Products for the Years 2014, 2025 & 2030
    • TABLE 158: Mexico Recent Past, Current & Future Analysis for Hematocrit Test Devices by End-user - Hospitals / Ambulatory Surgery Centers End-User, Clinics End-User, Diagnostic & Pathology Labs End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Mexico Historic Review for Hematocrit Test Devices by End-user - Hospitals / Ambulatory Surgery Centers End-User, Clinics End-User, Diagnostic & Pathology Labs End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 160: Mexico 16-Year Perspective for Hematocrit Test Devices by End-user - Percentage Breakdown of Value Sales for Hospitals / Ambulatory Surgery Centers End-User, Clinics End-User, Diagnostic & Pathology Labs End-User and Other End-Users for the Years 2014, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 161: Rest of Latin America Recent Past, Current & Future Analysis for Hematocrit Test Devices by Product - Blood Analyzers, Hematocrit Test Meters and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 162: Rest of Latin America Historic Review for Hematocrit Test Devices by Product - Blood Analyzers, Hematocrit Test Meters and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 163: Rest of Latin America 16-Year Perspective for Hematocrit Test Devices by Product - Percentage Breakdown of Value Sales for Blood Analyzers, Hematocrit Test Meters and Other Products for the Years 2014, 2025 & 2030
    • TABLE 164: Rest of Latin America Recent Past, Current & Future Analysis for Hematocrit Test Devices by End-user - Hospitals / Ambulatory Surgery Centers End-User, Clinics End-User, Diagnostic & Pathology Labs End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 165: Rest of Latin America Historic Review for Hematocrit Test Devices by End-user - Hospitals / Ambulatory Surgery Centers End-User, Clinics End-User, Diagnostic & Pathology Labs End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 166: Rest of Latin America 16-Year Perspective for Hematocrit Test Devices by End-user - Percentage Breakdown of Value Sales for Hospitals / Ambulatory Surgery Centers End-User, Clinics End-User, Diagnostic & Pathology Labs End-User and Other End-Users for the Years 2014, 2025 & 2030
  • MIDDLE EAST
    • Hematocrit Test Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 167: Middle East Recent Past, Current & Future Analysis for Hematocrit Test Devices by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 168: Middle East Historic Review for Hematocrit Test Devices by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 169: Middle East 16-Year Perspective for Hematocrit Test Devices by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2025 & 2030
    • TABLE 170: Middle East Recent Past, Current & Future Analysis for Hematocrit Test Devices by Product - Blood Analyzers, Hematocrit Test Meters and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 171: Middle East Historic Review for Hematocrit Test Devices by Product - Blood Analyzers, Hematocrit Test Meters and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 172: Middle East 16-Year Perspective for Hematocrit Test Devices by Product - Percentage Breakdown of Value Sales for Blood Analyzers, Hematocrit Test Meters and Other Products for the Years 2014, 2025 & 2030
    • TABLE 173: Middle East Recent Past, Current & Future Analysis for Hematocrit Test Devices by End-user - Hospitals / Ambulatory Surgery Centers End-User, Clinics End-User, Diagnostic & Pathology Labs End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 174: Middle East Historic Review for Hematocrit Test Devices by End-user - Hospitals / Ambulatory Surgery Centers End-User, Clinics End-User, Diagnostic & Pathology Labs End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 175: Middle East 16-Year Perspective for Hematocrit Test Devices by End-user - Percentage Breakdown of Value Sales for Hospitals / Ambulatory Surgery Centers End-User, Clinics End-User, Diagnostic & Pathology Labs End-User and Other End-Users for the Years 2014, 2025 & 2030
  • IRAN
    • TABLE 176: Iran Recent Past, Current & Future Analysis for Hematocrit Test Devices by Product - Blood Analyzers, Hematocrit Test Meters and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 177: Iran Historic Review for Hematocrit Test Devices by Product - Blood Analyzers, Hematocrit Test Meters and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 178: Iran 16-Year Perspective for Hematocrit Test Devices by Product - Percentage Breakdown of Value Sales for Blood Analyzers, Hematocrit Test Meters and Other Products for the Years 2014, 2025 & 2030
    • TABLE 179: Iran Recent Past, Current & Future Analysis for Hematocrit Test Devices by End-user - Hospitals / Ambulatory Surgery Centers End-User, Clinics End-User, Diagnostic & Pathology Labs End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 180: Iran Historic Review for Hematocrit Test Devices by End-user - Hospitals / Ambulatory Surgery Centers End-User, Clinics End-User, Diagnostic & Pathology Labs End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 181: Iran 16-Year Perspective for Hematocrit Test Devices by End-user - Percentage Breakdown of Value Sales for Hospitals / Ambulatory Surgery Centers End-User, Clinics End-User, Diagnostic & Pathology Labs End-User and Other End-Users for the Years 2014, 2025 & 2030
  • ISRAEL
    • TABLE 182: Israel Recent Past, Current & Future Analysis for Hematocrit Test Devices by Product - Blood Analyzers, Hematocrit Test Meters and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 183: Israel Historic Review for Hematocrit Test Devices by Product - Blood Analyzers, Hematocrit Test Meters and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 184: Israel 16-Year Perspective for Hematocrit Test Devices by Product - Percentage Breakdown of Value Sales for Blood Analyzers, Hematocrit Test Meters and Other Products for the Years 2014, 2025 & 2030
    • TABLE 185: Israel Recent Past, Current & Future Analysis for Hematocrit Test Devices by End-user - Hospitals / Ambulatory Surgery Centers End-User, Clinics End-User, Diagnostic & Pathology Labs End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 186: Israel Historic Review for Hematocrit Test Devices by End-user - Hospitals / Ambulatory Surgery Centers End-User, Clinics End-User, Diagnostic & Pathology Labs End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 187: Israel 16-Year Perspective for Hematocrit Test Devices by End-user - Percentage Breakdown of Value Sales for Hospitals / Ambulatory Surgery Centers End-User, Clinics End-User, Diagnostic & Pathology Labs End-User and Other End-Users for the Years 2014, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 188: Saudi Arabia Recent Past, Current & Future Analysis for Hematocrit Test Devices by Product - Blood Analyzers, Hematocrit Test Meters and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 189: Saudi Arabia Historic Review for Hematocrit Test Devices by Product - Blood Analyzers, Hematocrit Test Meters and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 190: Saudi Arabia 16-Year Perspective for Hematocrit Test Devices by Product - Percentage Breakdown of Value Sales for Blood Analyzers, Hematocrit Test Meters and Other Products for the Years 2014, 2025 & 2030
    • TABLE 191: Saudi Arabia Recent Past, Current & Future Analysis for Hematocrit Test Devices by End-user - Hospitals / Ambulatory Surgery Centers End-User, Clinics End-User, Diagnostic & Pathology Labs End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 192: Saudi Arabia Historic Review for Hematocrit Test Devices by End-user - Hospitals / Ambulatory Surgery Centers End-User, Clinics End-User, Diagnostic & Pathology Labs End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 193: Saudi Arabia 16-Year Perspective for Hematocrit Test Devices by End-user - Percentage Breakdown of Value Sales for Hospitals / Ambulatory Surgery Centers End-User, Clinics End-User, Diagnostic & Pathology Labs End-User and Other End-Users for the Years 2014, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 194: UAE Recent Past, Current & Future Analysis for Hematocrit Test Devices by Product - Blood Analyzers, Hematocrit Test Meters and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 195: UAE Historic Review for Hematocrit Test Devices by Product - Blood Analyzers, Hematocrit Test Meters and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 196: UAE 16-Year Perspective for Hematocrit Test Devices by Product - Percentage Breakdown of Value Sales for Blood Analyzers, Hematocrit Test Meters and Other Products for the Years 2014, 2025 & 2030
    • TABLE 197: UAE Recent Past, Current & Future Analysis for Hematocrit Test Devices by End-user - Hospitals / Ambulatory Surgery Centers End-User, Clinics End-User, Diagnostic & Pathology Labs End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 198: UAE Historic Review for Hematocrit Test Devices by End-user - Hospitals / Ambulatory Surgery Centers End-User, Clinics End-User, Diagnostic & Pathology Labs End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 199: UAE 16-Year Perspective for Hematocrit Test Devices by End-user - Percentage Breakdown of Value Sales for Hospitals / Ambulatory Surgery Centers End-User, Clinics End-User, Diagnostic & Pathology Labs End-User and Other End-Users for the Years 2014, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 200: Rest of Middle East Recent Past, Current & Future Analysis for Hematocrit Test Devices by Product - Blood Analyzers, Hematocrit Test Meters and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 201: Rest of Middle East Historic Review for Hematocrit Test Devices by Product - Blood Analyzers, Hematocrit Test Meters and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 202: Rest of Middle East 16-Year Perspective for Hematocrit Test Devices by Product - Percentage Breakdown of Value Sales for Blood Analyzers, Hematocrit Test Meters and Other Products for the Years 2014, 2025 & 2030
    • TABLE 203: Rest of Middle East Recent Past, Current & Future Analysis for Hematocrit Test Devices by End-user - Hospitals / Ambulatory Surgery Centers End-User, Clinics End-User, Diagnostic & Pathology Labs End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 204: Rest of Middle East Historic Review for Hematocrit Test Devices by End-user - Hospitals / Ambulatory Surgery Centers End-User, Clinics End-User, Diagnostic & Pathology Labs End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 205: Rest of Middle East 16-Year Perspective for Hematocrit Test Devices by End-user - Percentage Breakdown of Value Sales for Hospitals / Ambulatory Surgery Centers End-User, Clinics End-User, Diagnostic & Pathology Labs End-User and Other End-Users for the Years 2014, 2025 & 2030
  • AFRICA
    • Hematocrit Test Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 206: Africa Recent Past, Current & Future Analysis for Hematocrit Test Devices by Product - Blood Analyzers, Hematocrit Test Meters and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 207: Africa Historic Review for Hematocrit Test Devices by Product - Blood Analyzers, Hematocrit Test Meters and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 208: Africa 16-Year Perspective for Hematocrit Test Devices by Product - Percentage Breakdown of Value Sales for Blood Analyzers, Hematocrit Test Meters and Other Products for the Years 2014, 2025 & 2030
    • TABLE 209: Africa Recent Past, Current & Future Analysis for Hematocrit Test Devices by End-user - Hospitals / Ambulatory Surgery Centers End-User, Clinics End-User, Diagnostic & Pathology Labs End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 210: Africa Historic Review for Hematocrit Test Devices by End-user - Hospitals / Ambulatory Surgery Centers End-User, Clinics End-User, Diagnostic & Pathology Labs End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 211: Africa 16-Year Perspective for Hematocrit Test Devices by End-user - Percentage Breakdown of Value Sales for Hospitals / Ambulatory Surgery Centers End-User, Clinics End-User, Diagnostic & Pathology Labs End-User and Other End-Users for the Years 2014, 2025 & 2030

IV. COMPETITION

샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제